CN111903803A - Huangrong blood sugar reducing tea and preparation method thereof - Google Patents
Huangrong blood sugar reducing tea and preparation method thereof Download PDFInfo
- Publication number
- CN111903803A CN111903803A CN202010904149.8A CN202010904149A CN111903803A CN 111903803 A CN111903803 A CN 111903803A CN 202010904149 A CN202010904149 A CN 202010904149A CN 111903803 A CN111903803 A CN 111903803A
- Authority
- CN
- China
- Prior art keywords
- tea
- parts
- huangrong
- hypoglycemic
- leaves
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001603 reducing effect Effects 0.000 title abstract description 8
- 239000008280 blood Substances 0.000 title abstract description 7
- 210000004369 blood Anatomy 0.000 title abstract description 7
- 238000002360 preparation method Methods 0.000 title description 6
- 241001122767 Theaceae Species 0.000 title 1
- 244000269722 Thea sinensis Species 0.000 claims abstract description 82
- 235000013616 tea Nutrition 0.000 claims abstract description 79
- 241000196324 Embryophyta Species 0.000 claims abstract description 15
- 239000000419 plant extract Substances 0.000 claims abstract description 15
- 244000130270 Fagopyrum tataricum Species 0.000 claims abstract description 9
- 235000014693 Fagopyrum tataricum Nutrition 0.000 claims abstract description 9
- 244000302512 Momordica charantia Species 0.000 claims abstract description 9
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 9
- 240000000249 Morus alba Species 0.000 claims abstract description 8
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 8
- 235000019605 sweet taste sensations Nutrition 0.000 claims abstract description 7
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 claims abstract description 5
- 235000001553 Betula platyphylla Nutrition 0.000 claims abstract description 4
- 241001313086 Betula platyphylla Species 0.000 claims abstract description 4
- 235000019224 Camellia sinensis var Qingmao Nutrition 0.000 claims abstract description 4
- 241000414067 Inonotus obliquus Species 0.000 claims abstract description 4
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims abstract description 4
- 235000018365 Momordica dioica Nutrition 0.000 claims abstract description 4
- 244000228451 Stevia rebaudiana Species 0.000 claims abstract description 4
- 239000000796 flavoring agent Substances 0.000 claims abstract description 4
- 235000019634 flavors Nutrition 0.000 claims abstract description 4
- 235000020339 pu-erh tea Nutrition 0.000 claims abstract description 4
- 235000006092 Stevia rebaudiana Nutrition 0.000 claims abstract description 3
- 230000002218 hypoglycaemic effect Effects 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 7
- 238000004898 kneading Methods 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 241000628997 Flos Species 0.000 claims description 3
- 235000006468 Thea sinensis Nutrition 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 3
- 230000000996 additive effect Effects 0.000 claims description 3
- 238000007605 air drying Methods 0.000 claims description 3
- 235000020279 black tea Nutrition 0.000 claims description 3
- 235000009508 confectionery Nutrition 0.000 claims description 3
- 230000018044 dehydration Effects 0.000 claims description 3
- 238000006297 dehydration reaction Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000001125 extrusion Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract description 10
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 102000004877 Insulin Human genes 0.000 abstract description 5
- 108090001061 Insulin Proteins 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 5
- 229940125396 insulin Drugs 0.000 abstract description 5
- 230000000694 effects Effects 0.000 description 9
- 239000000126 substance Substances 0.000 description 8
- 239000002994 raw material Substances 0.000 description 3
- 230000023852 carbohydrate metabolic process Effects 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/12—Rolling or shredding tea leaves
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the technical field of tea processing, in particular to a Huangrong blood sugar reducing tea, which comprises the following components in part by weight: tea, inonotus obliquus, mulberry leaf, balsam pear, tartary buckwheat, natural plants with sweet taste and functional plant extracts are mixed; 7-8 parts of tea flavor, 1.5-2.5 parts of betula platyphylla, 1-2 parts of mulberry leaf, 0.6-0.8 part of bitter gourd, 1.2-2.4 parts of tartary buckwheat, and 2-4 parts of natural plant and functional plant extract. The tea is Pu' er tea, the natural plant with sweet taste is stevia rebaudiana, and the functional plant extract is from radix scrophulariae. The invention aims to reduce the dosage of the medicine or the insulin of the diabetic, prevent or delay the occurrence of the disease and relieve the psychological pain of the patient with the diabetes.
Description
Technical Field
The invention relates to the technical field of tea processing, and particularly relates to a Huangrong blood-glucose-reducing tea and a preparation method thereof.
Background
The incidence rate of the grain urine disease is extremely high at the present stage of China, according to statistics, diabetics in the whole country break through 9000 thousands of people, 1 case of every 10 adults is generated, and the grain urine disease is the country with the most diabetes in the world. At present, the treatment of the diabetes patients depends on drug treatment and insulin injection treatment, the treatment effect is not ideal, most of the diseases occur, and great thought pressure is caused to the diabetes patients. Therefore, the invention of the blood sugar reducing tea has remarkable blood sugar reducing effect and has wide social requirements in society.
Disclosure of Invention
The invention aims to provide the hypoglycemic tea capable of effectively assisting in treating diabetes, reducing the dosage of medicaments or insulin for patients with diabetes, preventing or delaying the occurrence of complications and relieving psychological pain of patients with diabetes.
In order to achieve the purpose, the invention provides the following technical scheme: a Huangrong hypoglycemic tea is characterized by comprising the following components: tea, inonotus obliquus, mulberry leaf, balsam pear, tartary buckwheat, natural plants with sweet taste and functional plant extracts are mixed; 7-8 parts of tea flavor, 1.5-2.5 parts of betula platyphylla, 1-2 parts of mulberry leaf, 0.6-0.8 part of bitter gourd, 1.2-2.4 parts of tartary buckwheat, and 2-4 parts of natural plant and functional plant extract.
Preferably, the tea leaves are Pu' er tea.
Preferably, the tea leaves are black tea.
Preferably, the natural plant having sweetness is stevia.
Preferably, the functional plant extract is from radix scrophulariae.
Preferably, the preparation method of the Huangrong hypoglycemic tea comprises the following steps:
step one, primary processing; controlling water and deactivating enzyme of fresh tea to obtain dry tea; drying flos Caryophylli, herba Rosmarini officinalis, herba Elsholtziae Calycocarpae, and sweet natural plant and functional plant extract to obtain dry additive;
step two, fumigating the dry tea leaves, and kneading the tea leaves into tea strips; and the dry materials are rolled into the leaves of the tea leaves in the kneading process;
step three, interweaving the tea strips to obtain tea strips;
fourthly, overlapping and stacking the tea strips in multiple layers, and performing extrusion dehydration to generate tea blocks;
and fifthly, carrying out sunlight air drying on the tea blocks, and ensuring that the water content is less than 10%.
The invention has the beneficial effects that: through the reasonable compatibility of the substances, the substances generate good synergistic effect on the curative effect, enhance the activity of insulin and accelerate the glycometabolism, thereby achieving the purpose of reducing the blood sugar. The invention is based on the principle of ancient training that tea is a medicine for all diseases. The substances are integrated and combined to form the mixed tea of the substances, and the group fights and coordinates with each other to exert the good effect of the tea therapy. The hypoglycemic tea has the advantages of small physical state of the monomer, large contact area with water, quick brewing and higher concentration. The invention has the advantages of high integrated concentration, high solubility, convenient use and no toxic or side effect compared with the prior art.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, it is obvious that the drawings in the following description are only some embodiments of the present invention, and for those skilled in the art, other drawings can be obtained according to the drawings without creative efforts.
FIG. 1 is a flow chart of the preparation method of the present invention.
Detailed Description
The technical solutions of the present invention will be described clearly and completely with reference to the accompanying drawings, and it is to be understood that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The first embodiment is as follows:
a Huangrong hypoglycemic tea is characterized by comprising the following components: tea, inonotus obliquus, mulberry leaf, balsam pear, tartary buckwheat, natural plants with sweet taste and functional plant extracts are mixed; 7-8 parts of tea flavor, 1.5-2.5 parts of betula platyphylla, 1-2 parts of mulberry leaf, 0.6-0.8 part of bitter gourd, 1.2-2.4 parts of tartary buckwheat, and 2-4 parts of natural plant and functional plant extract. The tea is Pu' er tea or black tea, the natural plant with sweet taste is stevia rebaudiana, and the functional plant extract is from radix scrophulariae.
Through the reasonable compatibility of the substances, the substances generate good synergistic effect on the curative effect, enhance the activity of insulin and accelerate the glycometabolism, thereby achieving the purpose of reducing the blood sugar. The invention is based on the principle of ancient training that tea is a medicine for all diseases. The substances are integrated and combined to form the mixed tea of the substances, and the group fights and coordinates with each other to exert the good effect of the tea therapy. The hypoglycemic tea has the advantages of small physical state of the monomer, large contact area with water, quick brewing and higher concentration. The invention has the advantages of high integrated concentration, high solubility, convenient use and no toxic or side effect compared with the prior art.
Example two:
according to the steps of fig. 1, the preparation method of the Huangrong hypoglycemic tea comprises the following steps:
step one, primary processing; controlling water and deactivating enzyme of fresh tea to obtain dry tea; drying flos Caryophylli, herba Rosmarini officinalis, herba Elsholtziae Calycocarpae, and sweet natural plant and functional plant extract to obtain dry additive;
step two, fumigating the dry tea leaves, and kneading the tea leaves into tea strips; and the dry materials are rolled into the leaves of the tea leaves in the kneading process;
step three, interweaving the tea strips to obtain tea strips;
fourthly, overlapping and stacking the tea strips in multiple layers, and performing extrusion dehydration to generate tea blocks;
and fifthly, carrying out sunlight air drying on the tea blocks, and ensuring that the water content is less than 10%.
According to the method, bitter raw materials, bitter gourds and tartary buckwheat are wrapped in the leaves of the tea, and the leaves of the tea are stably reinforced in a weaving and extruding mode, so that the influence on the taste of the tea caused by excessive bitter raw materials entering the tea water is avoided; during the infusion process, the tea leaves are slowly softened, so that the bitter raw materials wrapped in the tea leaves slowly emit the components through the tea leaves, and the delicate taste is ensured.
The above description is only for the specific embodiments of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present invention, and all the changes or substitutions should be covered within the scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the claims.
Claims (6)
1. A Huangrong hypoglycemic tea is characterized by comprising the following components: tea, inonotus obliquus, mulberry leaf, balsam pear, tartary buckwheat, natural plants with sweet taste and functional plant extracts are mixed;
7-8 parts of tea flavor, 1.5-2.5 parts of betula platyphylla, 1-2 parts of mulberry leaf, 0.6-0.8 part of bitter gourd, 1.2-2.4 parts of tartary buckwheat, and 2-4 parts of natural plant and functional plant extract.
2. The Huangrong hypoglycemic tea according to claim 1, wherein: the tea is Pu' er tea.
3. The Huangrong hypoglycemic tea according to claim 1, wherein: the tea is black tea.
4. The Huangrong hypoglycemic tea according to claim 1, wherein: the natural plant with sweet taste is stevia rebaudiana.
5. The Huangrong hypoglycemic tea according to claim 1, wherein: the functional plant extract is from radix scrophulariae.
6. A method for preparing the Huangrong hypoglycemic tea, which is used for any one of the claims 1 to 5, and is characterized in that: the method comprises the following steps:
step one, primary processing; controlling water and deactivating enzyme of fresh tea to obtain dry tea; drying flos Caryophylli, herba Rosmarini officinalis, herba Elsholtziae Calycocarpae, and sweet natural plant and functional plant extract to obtain dry additive;
step two, fumigating the dry tea leaves, and kneading the tea leaves into tea strips; and the dry materials are rolled into the leaves of the tea leaves in the kneading process;
step three, interweaving the tea strips to obtain tea strips;
fourthly, overlapping and stacking the tea strips in multiple layers, and performing extrusion dehydration to generate tea blocks;
and fifthly, carrying out sunlight air drying on the tea blocks, and ensuring that the water content is less than 10%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010904149.8A CN111903803A (en) | 2020-09-01 | 2020-09-01 | Huangrong blood sugar reducing tea and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010904149.8A CN111903803A (en) | 2020-09-01 | 2020-09-01 | Huangrong blood sugar reducing tea and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111903803A true CN111903803A (en) | 2020-11-10 |
Family
ID=73267440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010904149.8A Pending CN111903803A (en) | 2020-09-01 | 2020-09-01 | Huangrong blood sugar reducing tea and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111903803A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111903804A (en) * | 2020-09-01 | 2020-11-10 | 郭生云 | Smell-removing tea and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102754710A (en) * | 2012-06-07 | 2012-10-31 | 王宇 | Blood sugar lowering tea |
| CN103168882A (en) * | 2011-12-26 | 2013-06-26 | 镇江市丹徒区南山溪园茶叶专业合作社 | Health-care tea beneficial to reducing blood glucose and slowing down diabetic complications |
| CN105145972A (en) * | 2015-08-13 | 2015-12-16 | 句容市东方紫酒业有限公司 | Mulberry leaf flower and herbal tea and preparation method thereof |
| CN106605822A (en) * | 2016-12-19 | 2017-05-03 | 西安源森生物科技有限公司 | Composition facilitating reducing of blood sugar and preparation method of composition |
-
2020
- 2020-09-01 CN CN202010904149.8A patent/CN111903803A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103168882A (en) * | 2011-12-26 | 2013-06-26 | 镇江市丹徒区南山溪园茶叶专业合作社 | Health-care tea beneficial to reducing blood glucose and slowing down diabetic complications |
| CN102754710A (en) * | 2012-06-07 | 2012-10-31 | 王宇 | Blood sugar lowering tea |
| CN105145972A (en) * | 2015-08-13 | 2015-12-16 | 句容市东方紫酒业有限公司 | Mulberry leaf flower and herbal tea and preparation method thereof |
| CN106605822A (en) * | 2016-12-19 | 2017-05-03 | 西安源森生物科技有限公司 | Composition facilitating reducing of blood sugar and preparation method of composition |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111903804A (en) * | 2020-09-01 | 2020-11-10 | 郭生云 | Smell-removing tea and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103168871B (en) | Tea with blood sugar reducing efficacy and preparation method of tea | |
| CN104740308B (en) | A kind of hypoglycemic oral liquid of medical bio and preparation method thereof | |
| CN111035649A (en) | NMN + GLP compound nutritional supplement and preparation method and application thereof | |
| CN104082672A (en) | Health-preserving porridge with efficacy of reducing blood sugar level and production method of porridge | |
| CN101828660B (en) | Health-care food for hyperglycemia patient | |
| KR101387695B1 (en) | The anti-diabetic composition mainly containing extracts of kudzu root, Solomon's seal and E. senticosus | |
| CN111903803A (en) | Huangrong blood sugar reducing tea and preparation method thereof | |
| CN107412284A (en) | Treat food drug composition, the preparation method and applications of diabetes | |
| CN111317808A (en) | Hui drug enzyme for improving physique of diabetes patients | |
| CN1907374A (en) | Chinese medicinal composition for treating oral disease | |
| CN105412604A (en) | Traditional Chinese medicine composition for auxiliary treatment of diabetes and preparation method of traditional Chinese medicine composition | |
| CN102125128A (en) | Nine-ingredient blood sugar reducing tea | |
| CN108260682A (en) | A kind of hypoglycemic, reducing blood lipid and the health protection tea of blood pressure lowering | |
| CN107712890A (en) | A kind of antitoxic heart-soothing and sedative cream taste and preparation method thereof | |
| CN104825750B (en) | The preparation of a kind of Flos Ginseng processed and preparation method | |
| CN102068482B (en) | Orpine total flavones as well as extraction method and drug use thereof | |
| CN104673573A (en) | Wine with diabetes prevention and treatment function and preparation method thereof | |
| CN105055828A (en) | Traditional Chinese medicine preparation for treating chronic pharyngitis and preparing method thereof | |
| CN104474103A (en) | Natural plant hypoglycemic agent and preparation method thereof | |
| CN109091598A (en) | A kind of oral nursing liquid and its processing technology | |
| CN102743552A (en) | Tea for removing smoke and clearing away lung-heat and preparation method thereof | |
| KR102203094B1 (en) | Composition for preventing and improving menstrual pain and skin troubles | |
| CN108478739A (en) | A kind of health products and preparation method thereof adjusting equilibrium between yin and yang | |
| CN107823384A (en) | A kind of reducing blood lipid hypoglycemic traditional Chinese medicine composition and preparation method thereof | |
| CN107737241A (en) | Treat sophora bud Chinese medicine composition of diabetes and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201110 |